Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

Part of paid clinical trials in Portland, Oregon.

Sponsor
Providence Health & Services
Study ID
NCT03289364
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Penguin Cold Caps — DEVICE
    Patients will wear Penguin Cold Cap scalp cooling device prior to each chemotherapy administration, during administration, and for four hours following administration.

Study Details

The goal of this study is to estimate the efficacy of Penguin cold caps in preventing or reducing hair loss in patients receiving (neo)adjuvant chemotherapy (one of four common regimens) for early stage breast cancer.

Key Dates

Start date
Aug 24, 2017
Status verified
Apr 2026
Primary completion
Aug 19, 2021
Completion
Aug 19, 2021

Study Design

Enrollment
12 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Penguin Cold Caps
    Penguin Cold-cap therapy will commence at least 50 minutes prior to chemotherapy infusion, and will continue for 4 hours following completion of chemotherapy.

Primary Outcome Measure

Efficacy of PenguinTM Cold-caps for Prevention or Reduction of CIA [ Time Frame: 30 days post chemotherapy treatment ]

Locations (1)

FacilityCityStateZIPSite coordinators
Providence Cancer CenterPortlandOregon97213-

Find similar trials in Portland, OR

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Providence Cancer Center· Portland, OR

Related Studies